Clinical Trial Update: Dyslipidemia Management in Chinese Post Stroke Patients

View source ↗

Summary

A completed clinical trial update assessing dyslipidemia management in Chinese patients after stroke, sponsored by AstraZeneca.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: AstraZeneca | Conditions: Brain Ischemia,Stoke | Status: COMPLETED